JPRN-UMIN000034312招募中未知
Observation of changes in comprehensive immune pathology in chemotherapy including Nivolumab for patients with refractory malignant pleural mesothelioma - Observation of changes in comprehensive immune pathology in chemotherapy including Nivolumab for patients with refractory malignant pleural mesothelioma
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Initial and resectable malignant pleural mesothelioma
研究者
相似试验
已完成
不适用
Change in markers of immune function associated with Bacillus subtilis CU1 intervention in different age groupsNL-OMON51589Gnosis by Lesaffre90
招募中
不适用
Monitoring of the *healthy* immune response in the sentinel lymph node of patients undergoing a prophylactic mastectomy.Breastcancermammacarcinoma10006291NL-OMON36250Antoni van Leeuwenhoek Ziekenhuis20
招募中
4 期
Immune response after two doses of COVID-19 vaccinatioCoronavirus Disease 2019D000086382JPRN-jRCT1051210161Kayeka Hiroshi600
进行中（未招募）
不适用
A Clinical trial to analysis of immune profile following neoadjuvant chemotherapy in colorectal liver metastases patientsNeoplasmsKCT0003474Asan Medical Center20
已完成
不适用
Characterization of the immune response in patients with urothelial cell carcinoma of the bladder and during the BCG immunotherapy of bladder cancerC67Malignant neoplasm of bladderDRKS00003700Chirurgische Universitätsklinik, Abteilung für Urologie410